https://www.facebook.com/122099800706003425/

Dr Miruna Muha Endocrinolog, Dubai (2026)

07/09/2026

We are the most informed generation in history about health. We read labels, research symptoms and listen to wellness podcasts.

And only 68% of us have a primary care doctor.

The gap between health awareness and health action is one of the defining paradoxes of millennial health. We know more and do less preventively than any generation before us, largely because we feel fine and fine feels like evidence.

It is not.

The conditions that will affect millennial health most significantly in the next two decades are building right now, silently, without symptoms. Insulin resistance is measurable a decade before a diabetes diagnosis. Cardiovascular risk accumulates across the 30s and 40s without a clinical event. Hormonal shifts begin years before they produce the symptoms that finally send someone to a doctor.

Millennial women are 20% less healthy than their male counterparts, driven primarily by major depression, a condition that is also underdiagnosed and undertreated in this generation despite its measurable biological substrate.

Preventive medicine in your 30s and 40s is not cautious or premature. It is the decade when intervention carries the highest leverage and the lowest cost, in every sense of that word.

The window is open. Using it is a clinical decision worth making now.

Book your telemedicine consultation at endoage.eu

📎 References:
Wellmark / BCBSA Millennial Health Report
Tabak AG., Lancet, 2012

04/09/2026

The most expensive performance problem is not failure.

It is becoming so good at compensating that nobody — including you — notices the cost.

Many executives do not identify with the word “unwell.” They are still working, training, travelling, leading teams and meeting targets.

But performance can remain visible while capacity is quietly narrowing.

The better question is not:
“Can I keep going?”

It is:
“What is my current level of output costing me — and is it sustainable?”

Before the end of the year, consider reviewing three things:

1. What has become normal that should actually be investigated?
2. Which part of your routine depends on stimulants, willpower or recovery debt?
3. Would your current strategy support the next five years, not just the next five weeks?

High performance should not require you to ignore your own physiology.

What is the first sign that tells you your performance is becoming unsustainable?

Share your answer in the comments — or send us a private message if you would prefer to discuss it confidentially.

02/09/2026

Two patients. Same ferritin of 18 ng/mL. Completely different clinical pictures.

One is a 28-year-old endurance athlete with heavy periods and inadequate dietary iron. The other is a 58-year-old postmenopausal woman with chronic fatigue and no obvious dietary gaps. The number is identical. The mechanism is different. The clinical response is different. The history is what reveals which situation you are in.

This is why the first question matters more than the first biomarker.

Clinical history reveals which systems have been under pressure and for how long, what the patient's body has been through reproductively and hormonally, where chronic stress and sleep disruption have been accumulating and which patterns of symptoms connect across time in ways the patient may not have linked themselves.

That context is the lens through which every result is interpreted. Without it, a biomarker is a number without meaning. With it, the same number becomes a clinically specific answer to a clinically specific question.

The question that changed how I practice medicine: why this patient, why now, which mechanism. These three sit behind every first consultation. They turn a symptom into a biological story with a timeline, a driver and a direction.

Testing follows that story. The panel is selected because the history made those markers relevant, not because they appear on a standard template.

The history does not replace the biomarker. It tells the biomarker what question to answer.

Book your telemedicine consultation at endoage.eu

📎 References:
ESC Guidelines on Dyslipidaemias, 2021

31/08/2026

The most common thing we hear after a first consultation is not "I finally have answers."

It is "I finally understand what the questions actually are."

Most people arrive having already navigated a fragmented healthcare system alone. They pushed for better testing. They researched their symptoms. They found a clinician willing to look beyond the standard panel.

And then received a report with 40 values, a brief explanation and no clear path forward.

Understanding your biology is step one. Knowing what to do with that understanding, in the right sequence, with ongoing clinical support, is where most healthcare models stop short.

We are building something designed specifically for that gap.

More soon.

Follow EndoAge to be the first to know.

→ endoage.eu

30/08/2026

We are the generation that grew up on chips, pizza and convenience food and somehow stayed a size 10 through our 20s. Now we eat relatively well and our body responds to one bad week like it is a personal attack.

Nothing on the plate changed that dramatically. The biology underneath it did.

After 30, insulin sensitivity declines progressively, meaning the same glucose load from the same meal produces a higher insulin response and stores more readily as fat. Muscle mass begins declining at approximately 1% per year without deliberate resistance training, reducing the metabolic capacity that previously compensated for processed food without visible consequence. Hormonal shifts through the 30s and 40s change where and how fat is distributed, particularly viscerally.

Nearly 46.5% of young millennial women in the US are overweight or obese. This is not a generation-wide failure of discipline. It is a generation navigating significant metabolic and hormonal changes without the clinical tools to understand what is actually driving them.

The solution is not stricter dieting. It is understanding what changed biologically and addressing the three systems involved simultaneously: nutrition quality, resistance training to preserve metabolic muscle mass and hormonal assessment to identify what is amplifying the rest.

At EndoAge, that full picture is available through telemedicine, from wherever you are.

Book your consultation at endoage.eu

📎 References:
Women in the States / BCBSA data
Tabak AG., Lancet, 2012
Eurostat Fruit and Vegetable Consumption Data, 2019

26/08/2026

The most powerful thing in medicine is not a diagnostic technology or a therapeutic breakthrough.

It is a clinical relationship where someone holds your full history, recognizes patterns across time, coordinates care across systems and remains genuinely accessible when something shifts.

Most people have never experienced this consistently. Not because the medicine is unavailable. Because the conventional care model compresses the conditions that make it possible.

The average primary care consultation lasts 7 to 10 minutes. In that window, understanding why a symptom is present, what biological system is driving it and what the right clinical sequence looks like for this specific person is not possible. What is possible is a response to the presenting complaint. That is not the same thing.

Continuity means a clinician who holds the full timeline and reads the pattern within it. The fatigue today, the sleep disruption six months ago, the hormonal shift two years before that. These are connected. Episodic care never sees the connection because each encounter starts from the beginning.

Coordination means one clinical framework integrating every system, because the thyroid, the gut, the hormonal axis and the immune system do not divide themselves by specialty.

Accessibility means clinical questions answered in a timeframe relevant to the decision being made, not three weeks later when the moment has passed.

These are not luxury features. They are the conditions under which medicine produces consistent outcomes. What we have normalized as standard care is a compressed version of what clinical relationships need to be.

This is the model EndoAge is built to provide.

Book your telemedicine consultation at endoage.eu

📎 References:
Irving G., BMJ Open, 2017

24/08/2026

Prevention is one of the most misused words in medicine.

It is routinely applied to early detection, catching disease after it has already started, which is valuable but remains fundamentally reactive. True prevention operates upstream of detection, at the level of the biological trajectories that produce disease over years and decades.

P4 Medicine, a framework developed by systems biologist Leroy Hood, articulates what that upstream approach requires: Predictive, Preventive, Personalized and Participatory.

Predictive means identifying biological risk before clinical thresholds are crossed. Insulin resistance is measurable a decade before diagnosis. Coronary artery calcium accumulates silently before cardiac events. Inflammatory and hormonal shifts precede diagnosable conditions by years. These signals are measurable now. Acting on them now is where the largest clinical leverage exists.

Preventive in this framework means intervening at the mechanism level, not waiting for the outcome. Understanding why ApoB is elevated and addressing the metabolic and hormonal drivers before a plaque becomes clinically significant.

Personalized means building the clinical picture around individual biology, not population averages. The average patient does not exist. A 47-year-old woman in perimenopause with insulin resistance and elevated Lp(a) has a risk profile no standard guideline was designed around.

Participatory means patients who understand their own biology well enough to engage in decisions about it. That requires time, communication and continuity, three things conventional care models systematically compress.

The tools to practice this exist today. This is what we are building at EndoAge.

Book your telemedicine consultation at endoage.eu

📎 References:
Tabak AG., Lancet, 2012
Hood L., Science, 2004
Coulter A., BMJ, 2012

20/08/2026

The clinical reflex in most medical encounters is to order tests first and ask questions later, if at all.

I do it the other way around.

Not because testing is unimportant. Because a result without context is a number without meaning. The same ferritin, the same TSH, the same fasting glucose tells a completely different clinical story depending on who is holding it, what their history looks like and what their body has been carrying.

The first 45 minutes of a consultation at EndoAge cover personal and family history, medications, nutrition, sleep, movement, stress load and reproductive history when relevant. Not as a formality. As a clinical map that determines which tests are worth ordering and how to interpret what comes back.

Why you. Why now. Which mechanism. These are the three questions that guide every first consultation. They turn a symptom into a biological story with a beginning, a driver and a clinical direction.

Testing follows that story. The panel is selected for that specific person, not applied uniformly to everyone who walks through the door.

What follows testing is a roadmap: priorities, sequencing, monitoring, retesting and progress measures. Not a one-time prescription. A clinical relationship built across time.

This is where most medicine ends. It is where we start.

Book your telemedicine consultation at endoage.eu

18/08/2026

The longevity industry has a sequencing problem.

It sells the advanced chapter before most people have read the first one. Peptides, NAD infusions, epigenetic age tests and senolytic protocols are presented as the frontier of longevity medicine. Some of them have genuinely interesting science behind them. None of them produce meaningful results when placed on top of an unstable metabolic and hormonal foundation.

The interventions with the largest and most consistent effect on biological aging are not pharmaceutical. Skeletal muscle mass and strength predict all-cause mortality more accurately than most biomarkers. VO2max is the strongest non-invasive predictor of longevity available. Insulin sensitivity determines how fast metabolic aging accelerates. Sleep architecture governs hormonal recovery, inflammatory clearance and cognitive resilience simultaneously. Cardiovascular risk identified and managed early changes the trajectory of the following decades.

These are not the exciting interventions. They are the effective ones.

Epigenetic clocks are promising research tools, not yet validated as clinical endpoints for individual decision-making. IV antioxidant therapy adds limited benefit in the absence of documented deficiency. Wearables generate useful data when interpreted within a clinical framework and noise without one.

Longevity is not about adding years. It is about compressing the period of decline at the end of life, staying functional, strong and cognitively sharp for as long as possible. The gap between lifespan and healthspan is where most people spend their final decade. Narrowing that gap starts with the foundation, not the frontier.

Book your telemedicine consultation at endoage.eu

📎 References:
Lopez-Otin C., Cell, 2023
Mandsager K., JAMA Network Open, 2018

16/08/2026

Sleep culture has a lot to answer for.

We have turned poor sleep into a discipline problem, solved with routines, supplements, and tracking apps, when for a significant number of women the root cause is hormonal and metabolic, not behavioral.

Progesterone modulates GABA receptors, the same pathway sleep medications target. When it declines in perimenopause, often years before estrogen becomes the clinical conversation, the nervous system loses its primary natural calming signal. Cortisol dysregulation from chronic stress or blood sugar instability keeps the system in alert mode well into the night. Estrogen fluctuation fragments sleep architecture and reduces slow wave sleep, the phase where physical repair actually happens. Melatonin declines structurally with age regardless of screen time habits.

None of these respond to an earlier bedtime.

The clinical questions worth asking when sleep is persistently poor despite good habits: where is progesterone, is cortisol rhythm intact, is blood sugar stable through the night, is estrogen fluctuation contributing to fragmentation and is thyroid function affecting nervous system regulation after dark?

These are investigable questions with actionable answers.

Sleep is not a willpower metric. For many women it is one of the clearest readouts of what is happening hormonally and metabolically. Treating it as a behavioral problem when the driver is biological produces years of frustration and no resolution.

Book your telemedicine consultation at endoage.eu

📎 References:
Baulieu EE., PNAS, 2000
Leproult R., JAMA, 2011
Mong JA., Sleep Medicine Reviews, 2012

Dr Miruna Muha Endocrinolog

07/09/2026

04/09/2026

02/09/2026

31/08/2026

30/08/2026

26/08/2026

24/08/2026

20/08/2026

18/08/2026

16/08/2026

Address

Website

Alerts

Contact The Business

Shortcuts

Share

Category

Listing takedown request